Logo Image
|Slideshows|June 7, 2018

Psychiatric Times

  • Psychiatric Times Vol 36, Issue 5
  • Volume 36
  • Issue 5

5 Domains of Negative Symptoms of Schizophrenia

Negative symptoms identified from the Negative Symptom Assessment and the behaviors that might be observed in each of 5 domains.

To view the 2016 article in PDF format, click here.

Articles in this issue

over 7 years ago

Introduction: Meeting Our Personal and Professional Goals

over 7 years ago

Locum Psychiatric Practice: Unexpected, Unheralded Benefits

over 7 years ago

The Role of Social Media in Private Practice

over 7 years ago

Turning a Negative Into a Positive: Ways to Avoid and Overcome Negative Reviews

over 7 years ago

Disability: Overview of Concepts Psychiatrists Need to Know

over 7 years ago

Should We Prescribe Different Dosages of Psychotropic Medications to Men and Women?

over 7 years ago

Introduction to Immunotherapy of Malignancies for Psychiatrists

over 7 years ago

Cassandra or Happy Warrior: How Paradoxes of Psychiatry Can Sustain the Green New Deal

over 7 years ago

Treatment of Traumatic Brain Injury With Hyperbaric Oxygen Therapy

over 7 years ago

Looking for America

Related Content

Latest CME

Jersey City Psychiatry
In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Register now!
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia
Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

View more
Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

View more
(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more
Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

View more
Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia
Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

View more